位置:首页 > 蛋白库 > ENDUA_XENLA
ENDUA_XENLA
ID   ENDUA_XENLA             Reviewed;         292 AA.
AC   Q8JFY9;
DT   23-SEP-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   03-AUG-2022, entry version 60.
DE   RecName: Full=Poly(U)-specific endoribonuclease-A;
DE            EC=4.6.1.- {ECO:0000269|PubMed:12571235, ECO:0000269|PubMed:15755742};
DE   AltName: Full=Protein endoU-A;
DE   AltName: Full=Uridylate-specific endoribonuclease-A;
DE   AltName: Full=XendoU-A;
GN   Name=endou-a;
OS   Xenopus laevis (African clawed frog).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia;
OC   Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus; Xenopus.
OX   NCBI_TaxID=8355;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR
RP   LOCATION, SUBUNIT, COFACTOR, AND PROTEIN SEQUENCE OF 117-123; 137-142 AND
RP   276-284.
RC   TISSUE=Oocyte;
RX   PubMed=12571235; DOI=10.1074/jbc.m211937200;
RA   Laneve P., Altieri F., Fiori M.E., Scaloni A., Bozzoni I., Caffarelli E.;
RT   "Purification, cloning, and characterization of XendoU, a novel
RT   endoribonuclease involved in processing of intron-encoded small nucleolar
RT   RNAs in Xenopus laevis.";
RL   J. Biol. Chem. 278:13026-13032(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, COFACTOR,
RP   MUTAGENESIS OF GLU-92; SER-157; GLU-161; HIS-162; GLU-167; HIS-178;
RP   LYS-224; GLY-232; SER-234; PRO-235 AND GLU-236, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=15755742; DOI=10.1074/jbc.m501160200;
RA   Gioia U., Laneve P., Dlakic M., Arceci M., Bozzoni I., Caffarelli E.;
RT   "Functional characterization of XendoU, the endoribonuclease involved in
RT   small nucleolar RNA biosynthesis.";
RL   J. Biol. Chem. 280:18996-19002(2005).
RN   [3]
RP   FUNCTION, COFACTOR, AND SUBCELLULAR LOCATION.
RX   PubMed=7513048; DOI=10.1128/mcb.14.5.2966-2974.1994;
RA   Caffarelli E., Arese M., Santoro B., Fragapane P., Bozzoni I.;
RT   "In vitro study of processing of the intron-encoded U16 small nucleolar RNA
RT   in Xenopus laevis.";
RL   Mol. Cell. Biol. 14:2966-2974(1994).
RN   [4]
RP   FUNCTION, COFACTOR, AND SUBCELLULAR LOCATION.
RX   PubMed=9144568; DOI=10.1006/bbrc.1997.6487;
RA   Caffarelli E., Maggi L., Fatica A., Jiricny J., Bozzoni I.;
RT   "A novel Mn++-dependent ribonuclease that functions in U16 SnoRNA
RT   processing in X. laevis.";
RL   Biochem. Biophys. Res. Commun. 233:514-517(1997).
RN   [5]
RP   PURIFICATION, AND CRYSTALLIZATION.
RX   PubMed=16511328; DOI=10.1107/s1744309106006373;
RA   Renzi F., Panetta G., Vallone B., Brunori M., Arceci M., Bozzoni I.,
RA   Laneve P., Caffarelli E.;
RT   "Large-scale purification and crystallization of the endoribonuclease
RT   XendoU: troubleshooting with His-tagged proteins.";
RL   Acta Crystallogr. F 62:298-301(2006).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS), AND SUBUNIT.
RX   PubMed=16895992; DOI=10.1073/pnas.0602426103;
RA   Renzi F., Caffarelli E., Laneve P., Bozzoni I., Brunori M., Vallone B.;
RT   "The structure of the endoribonuclease XendoU: from small nucleolar RNA
RT   processing to severe acute respiratory syndrome coronavirus replication.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:12365-12370(2006).
CC   -!- FUNCTION: Poly(U)-specific endoribonuclease involved in the processing
CC       of intron-encoded box C/D snoRNAs, such as U16 and U86. Releases
CC       products that have 2',3'-cyclic phosphate termini at the 3'-end.
CC       {ECO:0000269|PubMed:12571235, ECO:0000269|PubMed:15755742,
CC       ECO:0000269|PubMed:7513048, ECO:0000269|PubMed:9144568}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=uridylyl-uridylyl-ribonucleotide-RNA = a 3'-end uridylyl-
CC         2',3'-cyclophospho-uridine-RNA + a 5'-end dephospho-ribonucleoside-
CC         RNA; Xref=Rhea:RHEA:67732, Rhea:RHEA-COMP:13936, Rhea:RHEA-
CC         COMP:17334, Rhea:RHEA-COMP:17335, ChEBI:CHEBI:138284,
CC         ChEBI:CHEBI:173079, ChEBI:CHEBI:173080;
CC         Evidence={ECO:0000269|PubMed:12571235, ECO:0000269|PubMed:15755742};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67733;
CC         Evidence={ECO:0000305|PubMed:12571235, ECO:0000305|PubMed:15755742};
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:12571235, ECO:0000269|PubMed:15755742,
CC         ECO:0000269|PubMed:7513048, ECO:0000269|PubMed:9144568};
CC       Note=In vitro, optimal manganese concentration is in the range of 5-10
CC       mM. {ECO:0000269|PubMed:12571235, ECO:0000269|PubMed:15755742,
CC       ECO:0000269|PubMed:7513048, ECO:0000269|PubMed:9144568};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 7.5. {ECO:0000269|PubMed:15755742};
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:12571235,
CC       ECO:0000269|PubMed:16895992}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12571235,
CC       ECO:0000269|PubMed:7513048, ECO:0000269|PubMed:9144568}.
CC   -!- SIMILARITY: Belongs to the ENDOU family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ507315; CAD45344.1; -; mRNA.
DR   RefSeq; NP_001081040.1; NM_001087571.1.
DR   PDB; 2C1W; X-ray; 2.20 A; A/B/C=1-292.
DR   PDBsum; 2C1W; -.
DR   AlphaFoldDB; Q8JFY9; -.
DR   SMR; Q8JFY9; -.
DR   MaxQB; Q8JFY9; -.
DR   GeneID; 394346; -.
DR   CTD; 394346; -.
DR   Xenbase; XB-GENE-5883648; endoul.L.
DR   EvolutionaryTrace; Q8JFY9; -.
DR   Proteomes; UP000186698; Genome assembly.
DR   Bgee; 394346; Expressed in oocyte and 19 other tissues.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0004521; F:endoribonuclease activity; IDA:UniProtKB.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0030145; F:manganese ion binding; TAS:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0043144; P:sno(s)RNA processing; TAS:UniProtKB.
DR   CDD; cd21159; XendoU; 1.
DR   InterPro; IPR039787; ENDOU.
DR   InterPro; IPR037227; EndoU-like.
DR   InterPro; IPR018998; EndoU_C.
DR   PANTHER; PTHR12439; PTHR12439; 1.
DR   Pfam; PF09412; XendoU; 1.
DR   SUPFAM; SSF142877; SSF142877; 1.
DR   PROSITE; PS51959; ENDOU; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; Endonuclease; Hydrolase; Lyase;
KW   Manganese; Metal-binding; Nuclease; Nucleus; Reference proteome;
KW   RNA-binding.
FT   CHAIN           1..292
FT                   /note="Poly(U)-specific endoribonuclease-A"
FT                   /id="PRO_0000350627"
FT   DOMAIN          8..285
FT                   /note="EndoU"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01304"
FT   ACT_SITE        162
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01304"
FT   ACT_SITE        178
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01304"
FT   ACT_SITE        224
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01304"
FT   MUTAGEN         92
FT                   /note="E->Q: No change in affinity for RNA substrate."
FT                   /evidence="ECO:0000269|PubMed:15755742"
FT   MUTAGEN         157
FT                   /note="S->A: No change in affinity for RNA substrate."
FT                   /evidence="ECO:0000269|PubMed:15755742"
FT   MUTAGEN         161
FT                   /note="E->Q: No effect. Loss of activity and affinity for
FT                   RNA substrate; when associated with Q-167."
FT                   /evidence="ECO:0000269|PubMed:15755742"
FT   MUTAGEN         162
FT                   /note="H->A: Loss of catalytic activity and affinity for
FT                   RNA substrate."
FT                   /evidence="ECO:0000269|PubMed:15755742"
FT   MUTAGEN         167
FT                   /note="E->Q: No effect. Loss of activity and affinity for
FT                   RNA substrate; when associated with Q-161."
FT                   /evidence="ECO:0000269|PubMed:15755742"
FT   MUTAGEN         178
FT                   /note="H->A: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:15755742"
FT   MUTAGEN         224
FT                   /note="K->A: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:15755742"
FT   MUTAGEN         232
FT                   /note="G->A: No change in affinity for RNA substrate."
FT                   /evidence="ECO:0000269|PubMed:15755742"
FT   MUTAGEN         234
FT                   /note="S->A: No change in affinity for RNA substrate."
FT                   /evidence="ECO:0000269|PubMed:15755742"
FT   MUTAGEN         235
FT                   /note="P->A: No change in affinity for RNA substrate."
FT                   /evidence="ECO:0000269|PubMed:15755742"
FT   MUTAGEN         236
FT                   /note="E->Q: Shows higher affinity for RNA substrate."
FT                   /evidence="ECO:0000269|PubMed:15755742"
FT   HELIX           10..21
FT                   /evidence="ECO:0007829|PDB:2C1W"
FT   TURN            30..32
FT                   /evidence="ECO:0007829|PDB:2C1W"
FT   STRAND          33..35
FT                   /evidence="ECO:0007829|PDB:2C1W"
FT   STRAND          39..42
FT                   /evidence="ECO:0007829|PDB:2C1W"
FT   STRAND          59..63
FT                   /evidence="ECO:0007829|PDB:2C1W"
FT   HELIX           65..68
FT                   /evidence="ECO:0007829|PDB:2C1W"
FT   TURN            69..71
FT                   /evidence="ECO:0007829|PDB:2C1W"
FT   HELIX           74..86
FT                   /evidence="ECO:0007829|PDB:2C1W"
FT   HELIX           96..109
FT                   /evidence="ECO:0007829|PDB:2C1W"
FT   HELIX           113..124
FT                   /evidence="ECO:0007829|PDB:2C1W"
FT   HELIX           132..144
FT                   /evidence="ECO:0007829|PDB:2C1W"
FT   HELIX           159..163
FT                   /evidence="ECO:0007829|PDB:2C1W"
FT   STRAND          168..171
FT                   /evidence="ECO:0007829|PDB:2C1W"
FT   HELIX           180..188
FT                   /evidence="ECO:0007829|PDB:2C1W"
FT   STRAND          192..197
FT                   /evidence="ECO:0007829|PDB:2C1W"
FT   STRAND          201..203
FT                   /evidence="ECO:0007829|PDB:2C1W"
FT   STRAND          211..219
FT                   /evidence="ECO:0007829|PDB:2C1W"
FT   STRAND          227..230
FT                   /evidence="ECO:0007829|PDB:2C1W"
FT   HELIX           235..247
FT                   /evidence="ECO:0007829|PDB:2C1W"
FT   STRAND          250..260
FT                   /evidence="ECO:0007829|PDB:2C1W"
FT   STRAND          263..272
FT                   /evidence="ECO:0007829|PDB:2C1W"
FT   STRAND          275..287
FT                   /evidence="ECO:0007829|PDB:2C1W"
SQ   SEQUENCE   292 AA;  33863 MW;  910ED803409E25A5 CRC64;
     MASNRGQLNH ELSKLFNELW DADQNRMKSG KDYRISLQGK AGYVPAGSNQ ARDSASFPLF
     QFVDEEKLKS RKTFATFISL LDNYEMDTGV AEVVTPEEIA ENNNFLDAIL ETKVMKMAHD
     YLVRKNQAKP TRNDFKVQLY NIWFQLYSRA PGSRPDSCGF EHVFVGESKR GQEMMGLHNW
     VQFYLQEKRK NIDYKGYVAR QNKSRPDEDD QVLNLQFNWK EMVKPVGSSF IGVSPEFEFA
     LYTIVFLASQ EKMSREVVRL EEYELQIVVN RHGRYIGTAY PVLLSTNNPD LY
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024